Bowers E, Griffith M, Kolfenbach J, Pearson D, Hammes A, Weinstein E. Quality Improvement Intervention to Reduce Thirty-Day Hospital Readmission Rates Among Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2022 Jan;74(1):126-130. PubMed PMID: 32860731
Bowers E, Griffith M, Kolfenbach J, Pearson D, Hammes A, Weinstein E. Quality Improvement Intervention to Reduce Thirty-Day Hospital Readmission Rates Among Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2022 Jan;74(1):126-130. PubMed PMID: 32860731
Matson SM, Griffith M, Lee JS. FocuSSced on the Target in Systemic Sclerosis-Interstitial Lung Disease: Another Arrow in the Quiver?. Am J Respir Crit Care Med. 2022 Mar 15;205(6):608-610. PubMed PMID: 34905698
Matson SM, Griffith M, Lee JS. FocuSSced on the Target in Systemic Sclerosis-Interstitial Lung Disease: Another Arrow in the Quiver?. Am J Respir Crit Care Med. 2021 Dec 14. [Epub ahead of print] PubMed PMID: 34905698
Pham AT, Rachubinski AL, Enriquez-Estrada B, Worek K, Griffith M, Espinosa JM. JAK inhibition for treatment of psoriatic arthritis in Down syndrome. Rheumatology (Oxford). 2021 Sep 1;60(9):e309-e311. PubMed PMID: 33630031
Pham AT, Rachubinski AL, Enriquez-Estrada B, Worek K, Griffith M, Espinosa JM. JAK inhibition for treatment of psoriatic arthritis in Down syndrome. Rheumatology (Oxford). 2021 Sep 1;60(9):e309-e311. doi: 10.1093/rheumatology/keab203. PMID: 33630031; PMCID: PMC8410001.